Dr. Susan Winters ☕️

@docwinter.bsky.social

Cheese lover, guitarist, physician-scientist investigating the role of inflammatory bio-markers in MS, amateur barista

COVID and EBV aren’t always “one and done.” In susceptible people, they can rev up B cells that make autoantibodies, erode immune tolerance, and feed pathways seen in lupus, MS, and Long COVID. Reinfection isn’t harmless. Fewer infections = fewer chances to trigger that machinery.

Molecular Pathways Driving Autoantibody Production Following SARS-CoV-2 Infection Identified

Findings suggest that SARS-CoV-2 infection can activate an immune program that closely resembles those involved in established autoimmune disorders.

genengnews.com

🚨 BREAKING 🚨 | COVID MAY WAKE THE VIRUSES SLEEPING INSIDE YOU In 1,154 hospitalized patients, researchers found dormant viruses like EBV and CMV reactivating, linked to worse COVID. One viral family was associated with long COVID

Virus reactivation in acute and long COVID-19 - Nature

Chronic reactivation of distinct herpesviruses and anelloviruses occur during acute and long COVID-19, and track with disease severity, inflammation and outcomes, revealing immune signatures with prog...

nature.com

🚨 The 2026 ACC/AHA dyslipidemia guideline just made 21 MILLION more Americans eligible for statins, over HALF of adults 30-79! New age range, lower risk thresholds, CKD & HIV added. Yet NO new low-risk statin trials since 2018. Big implications ahead. 💊

Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy

This cross-sectional study explores the 2026 guideline on dyslipidemia management, examining the population health impact on US adults recommended primary prevention statin therapy due to atherosclero...

jamanetwork.com

Big COVID news: the FDA just approved Xocova (ensitrelvir), the first oral antiviral shown to help prevent symptomatic COVID-19 after exposure. In the Phase 3 SCORPIO-PEP trial, it reduced the risk of symptomatic infection by 67% when started within 72 hours of household exposure. #BlueSky #Covid19

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts | NEJM

Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...

nejm.org

Big COVID news: the FDA just approved Xocova (ensitrelvir), the first oral antiviral shown to help prevent symptomatic COVID-19 after exposure. In the Phase 3 SCORPIO-PEP trial, it reduced the risk of symptomatic infection by 67% when started within 72 hours of household exposure. #BlueSky #Covid19

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts | NEJM

Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...

nejm.org

🚨 COVID BREAKTHROUGH: For the first time, an antiviral pill cut post-exposure symptomatic COVID from ~9% to ~3% in household contacts. For transplant patients, care-home residents and high-risk families, this could be massive. #COVID #PublicHealth #Medicine #Science #Health

At last, a pill that can prevent COVID after exposure to infected people

Drug arrives years after pandemic’s peak, but could still offer protection to vulnerable populations.

nature.com

🚨 COVID BREAKTHROUGH: For the first time, an antiviral pill cut post-exposure symptomatic COVID from ~9% to ~3% in household contacts. For transplant patients, care-home residents and high-risk families, this could be massive. #COVID #PublicHealth #Medicine #Science #Health

At last, a pill that can prevent COVID after exposure to infected people

Drug arrives years after pandemic’s peak, but could still offer protection to vulnerable populations.

nature.com

This is incredible. A simple vaccine during pregnancy cutting newborn hospitalizations from RSV by around 80% is exactly the kind of quiet breakthrough that changes lives. Protecting babies from day one is huge. Science at its best. #MedSky #Vaccines #Science #BlueSky

Pregnancy vaccine reduces baby hospital admissions for RSV by 80%

A study confirms the vaccine gives excellent protection for babies against life-threatening chest infections.

bbc.com

We may have been counting COVID deaths wrong. A new study suggests many deaths labeled as heart disease or pneumonia were likely COVID, especially early on. Not a conspiracy. Just messy data. If the toll was higher than reported… what else are we sure about that isn’t true? #MedSky #Covid19

Applying machine learning to identify unrecognized COVID-19 deaths recorded as other causes of death in the United States

A machine learning approach suggests that COVID-19 deaths were undercounted unevenly across sociodemographic groups in 2020–2021.

science.org

Exciting Nature study shows microbiome-driven gut inflammation disrupts vagus nerve signaling to the hippocampus, accelerating cognitive decline. In mice, restoring gut–brain signaling reversed memory loss. Happy to have new therapeutic targets to pursue! #AgingResearch #Longevity #MedSky

Intestinal interoceptive dysfunction drives age-associated cognitive decline - Nature

Age-related microbiome changes increase medium-chain fatty acid-producing bacteria, driving GPR84-mediated myeloid inflammation, impaired vagal signalling and hippocampal dysfunction; targeting this g...

nature.com

Stranger Things is fiction, but the Upside Down is built on real physics ideas like the many-worlds interpretation of quantum mechanics. Quantum events split reality into countless branches. No portals yet, but the math still works #StrangerThings #QuantumPhysics #SciComm #Science #Art

Are we living in a parallel universe? The strange physics of Stranger Things

Nature speaks to theoretical physicists to explore the real theories that inspired the hit series. Warning: contains spoilers.

nature.com